Integra LifeSciences (IART) 10-K2010 FY Annual report

Filed: 24 Feb 11, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: accreted, allied, AOCI, apparent, Arduini, ASA, austerity, biomechanical, Budde, carpel, catering, catheter, ceramic, cohesive, compromised, construct, correlation, Correspondingly, corroborated, Culley, DDD, disadvantage, disk, distortion, divided, DNB, dramatically, ear, elegant, endoscopy, evolution, flat, franchise, Hawthorne, HeliCote, HeliMEND, HeliPlug, HeliTape, highest, HSBC, Inception, inside, insignificant, intuitive, JP, lagged, Language, lieu, likelihood, NA, neurotrauma, NICU, nonfunctional, nose, pathology, Peter, prepaid, RBC, Reauthorization, remitted, rescission, rigid, rounding, simplicity, South, stream, suspended, tagged, TD, temporarily, text, theatre, therapeutic, throat, transforaminal, TRUJ, Unemployment, unhedged, unintended, unremitted, weaker, XBRL

Removed: accommodate, acquirer, adhesion, advancement, affirmative, anytime, barrier, begun, Bilayer, Bilthoven, Bimeco, biopsy, Bipolar, block, breach, Broach, brought, building, built, calling, cannulated, Canoga, carpal, Codman, commenced, compression, de, declaratory, deduction, designation, developmental, differentiation, dispose, dissolve, Distal, drove, duration, DynaGraft, EBITDA, eliminating, engineered, enhanced, epidural, escrow, FASB, fewer, fiber, floating, flowable, focusing, format, founded, fracture, FSP, guide, gutta, highlighted, hind, holding, ICP, ICU, improving, intention, intercarpal, Internacional, internationally, KMI, Lausanne, lay, leaseback, lighted, liquidate, liquidated, London, lose, Lyon, marginal, marked, mechanical, metabolic, Mexican, mini, mirror, mouth, Moyco, mutual, Nail, newly, nonconvertible, NV, offsetting, OmniSight, optic, OrthoBlast, paper, Park, patented, percha, precise, Precision, principle, professional, profit, Protector, Protocol, putty, Radial, receiving, recording, redemption, regularly, release, removing, rent, resorbable, restructure, retrospective, reviewing, SA, SAS, seasoned, segmentation, selection, shape, Shurtleff, southeastern, spent, square, standard, structured, subsequently, substitution, surgically, Suturable, Switzerland, tabular, targeted, tumor, utilization, vertebrae

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

IART similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

Certification of Principal Financial Officer
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

I, John B. Henneman, III, Executive Vice President, Finance and Administration, and Chief Financial Officer of Integra LifeSciences Holdings Corporation (the “Company”), hereby certify that, to my knowledge:

1.		The Annual Report on Form 10-K of the Company for the year ended December 31, 2010 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

2.		The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: February 23, 2011



	/s/ John B. Henneman, III
	John B. Henneman, III
	Executive Vice President, Finance and Administration, and Chief Financial Officer